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Figure 1. Computed tomography scan of the chest shows an expansive mass occupying
the left hemithorax extending from the abnormal rib. Tumor was located over posterior
arch of the left ninth rib.
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Ewing sarcoma or primitive neuroectodermal tumor (PNET) of bone is the second most common
pediatric malignant bone tumor. The median age at diagnosis is 15 years and there is a male predilection of
1.5/1. The authors present the case of a 14-year-old boy with Ewing sarcoma situated on the left ninth rib which
was being investigated for respiratory tract infection. Pleurisy is the most common misdiagnosis. Our case
illustrates the importance of recognizing exceptional features when interpreting FDG PET or scintigraphy to
prevent the misinterpretation of metastases as other etiologies, such as infection.
INTRODUCTION
Ewing sarcoma or primitive neuroectodermal tumor (PNET) of bone is the second most common pediatric
malignant bone tumor. The median age at diagnosis is 15 years and there is a male predilection of 1.5/1. PNET
are high-grade tumors that usually metastasize to lungs, pleural spaces and bones. The prognosis of the patients
changes significantly in the absence and presence of metastatic disease. Present algorithm workup includes:
computed tomography (CT) scan of the chest to study skeletal metastasis, magnetic resonance imaging (MRI) for
local tumor extent and Tc-99m whole-body scintigraphy to exclude skeletal metastasis. However, these techniques
differ in performance in terms of sensitivity and specificity, but none of the modalities alone seem to be able to yield
a reliable diagnostic outcome. FDG positron emission tomography (FDG PET) has the ability to image tumor
glucose metabolism noninvasively. FDG uptake is regarded as a surrogate marker for the degree of tumor
aggressiveness in many malignancies. Besides, FDG PET is an ideal method to assess tumor response. Presented
is a case of Ewing sarcoma of the rib which illustrates the importance of recognizing exceptional features when
interpreting FDG PET or scintigraphy to prevent the misinterpretation of metastases as perhaps other etiologies,
such as infection.
CASE REPORT
A 14-year-old boy presented to
the casualty department with
localized left-sided chest pain and
fever (August 2011). A plain chest
x-ray showed an opacity in the
base of the left lung. Patient was
being investigated for pneumonia
and treated with antibiotic during
10 days. Subsequently, the
patient consulted the emergency
ward about 2-days history of pain
in the left hip which radiates to
lumbar back and buttock,
asthenia and fever. A plain pelvis
x-ray was unremarkable. Patient
was diagnosed of acute
pharyngitis and treated. The
patient came to the casualty department, for the third time, with left flank severe pain, not cough, not dyspnea, not
nasal mucus and fever (38.6º). A plain chest x-ray showed a basal nodular opacity in the middle lobe of the lung
and other left basal paracardiac opacity very suggestive of encapsulated pleural effusion which is an uncommon
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Figure 2. (A): Bone scintigraphy scan was requested to rule out multiple lesions. The images
shows increased local tracer localization in the left ninth rib and it was discovered a new
lesion in the left sacral alae. (B): Coronal PET shows an area of increased FDG uptake in
the posterior arch of the left a maximum standard uptake value of 6.6.
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Figure 3. Follow-up imaging studies. (A): Coronal PET reveals a diffusing
increased uptake in the bone marrow, without foci, as a result of reaction to
postchemotherapy pancytopenia. (B): Scintigraphy does not show any bone
alteration.
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Figure 4. Axial pelvic magnetic
resonance imaging suggests bone
necrosis in the left sacral alae.
[enlarge]
radiological finding in young patients with chest pain. Multimodal medical imaging studies evidenced a rib mass [1].
It was biopsied and Ewing’s sarcoma was confirmed (September 2011). Functional medical imaging studies
evidenced an additional lesion in the sacral bone.
A computed tomography (CT)
(Fig. 1A, 1B) scan of the chest
showed an expansive mass
(80 x 45 x 60mm) occupying
the left hemithorax extending
from the abnormal rib. Tumor
was located over posterior
arch of the left ninth rib. A
second mass of 35 x 30 x
34mm located to the right
hemithorax, closed to right
atrium, at pleural level was
discovered. Bone scintigraphy
(Fig. 2A) scan was requested
to rule out multiple lesions.
The images showed increased
local tracer localization in the
left ninth rib and it was discovered a new lesion in the left sacral alae.
Wholebody PET (Fig. 2B), after injection of
171MBq of 18-F-FDG, showed an area of
increased FDG uptake in the posterior arch of
the left ninth rib with soft-tissue involvement
measuring 20 x 53 x 64 mm with a Maximum
Standard Uptakes Values (SUVmax) of 6.6,
suggesting a malignant nature. PET
confirmed an hypermetabolic homogeneous
solid well-demarcated mass closed to right
atrium 38 x 37 mm with an SUVmax of 12.4,
suggesting a malignant nature. PET detected
a little not well defined mass in the middle
lobe of the rigth lung measuring 11mm
(SUVmax 1.9), suggesting etiologies such as
infection or inflammation. Increased FDG
uptake in pelvis was seen numerous
millimeter focus in the left sacroiliac bone
(SUVmax 2.9), corresponding to the same pathological foci described on bone scintigraphy. A little abdominal focus
localized in large bowel (cecum) suggested a benign process.
Postchemotherapy 18-F-FDG PET (Fig. 3A) revealed a diffusing increased
uptake in the bone marrow, without foci, as a result of reaction to
postchemotherapy pancytopenia. The image showed a full disappearance
of rib tumor focus and right lung focus. Findings indicate a favorable
response to therapy. There was not hypermetabolic activity corresponding
to other pathological foci. The sacroiliac bone was difficult to assess due to
the diffusing increased uptake of FDG. Scintigraphy (Fig. 3B) did not show
any bone alteration. Pelvic magnetic resonance imaging (MRI) (Fig. 4)
suggesting bone necrosis in the left sacral alae. Restaging computed
tomography scan (Fig. 5) obtained following chemotherapy and surgery
showed a fibrotic scar in the posterior basal segment of the lung. The
bronchiectasis in the right lung suggested an infective airways disease in
resolution phase.
DISCUSSION
Ewing sarcoma is preferentially located in the long bones or in the pelvis, the
ribs being the third most frequent site (making up 10-15% of all cases) [2].
Ewing sarcoma is the most frequent chest wall tumor in children and
Figure 5. Axial chest CT obtained
following chemotherapy and surgery
shows a fibrotic scar in the posterior
basal segment of the lung.
adolescents [3]. Chest pain in children and adolescents leads to consideration
of a number of differential diagnoses: musculoskeletal trauma, pneumothorax,
pleurisy, myocarditis, pericarditis, respiratory infections, pleurodynia and bone
malignancies [4].
The description of the local extent of a bone tumor requires X-ray and CT/MRI
of the involved bone. A chest CT scan is required to rule out lung or pleural
metastases. The screening for bone metastases consists to include 99mTc
bone scintigraphy. Many centres are now using FDG-PET scanning or total-
body MRI to look for occult metastases. While the role of FDG PET-CT in
detecting recurrence is less clear, its role in staging Ewing sarcoma seems to
be well established [5]. Other authors state that MRI imaging with Gd
enhancement, FDG PET and thallium scan maybe useful for assessment after
treatment [6].
Recently, more accurate radiological diagnosis has become possible because of functional examinations such as
FDG PET. This case suggests that the importance of recognizing exceptional features when interpreting FDG PET
or scintigraphy to prevent the misinterpretation of metastases as perhaps other etiologies, such as infection [7].
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